By Abigail Summerville
NEW YORK, June 11 (Reuters) - O Positiv Health is exploring a sale that could value the women's health supplements company at around $1 billion, according to three people familiar with the matter.
The founder-owned business is working with investment bank Jefferies on the sale effort, said the sources, who added that O Positiv is projecting $275 million of revenue this year after generating around $225 million in 2024.
The sources cautioned that no deal was guaranteed, and spoke on condition of anonymity to discuss private information.
Jefferies declined to comment. O Positiv did not respond to a comment request.
Siblings Bobby and Brianna Bitton launched O Positiv in 2018. The company makes vitamins and probiotics that address a variety of health concerns, from PMS and menopause symptoms to vaginal and gut health.
The products are sold on the company's website, as well as through retailers including Walmart WMT.N, Target TGT.N and Amazon AMZN.O.
Consumer health companies and private equity firms alike have put more emphasis on investing in the women's health space in recent years, which has created a significant pool of buyers for brands founded by entrepreneurs.
Such deals include Pharmavite buying Bonafide in November 2023 and L Catterton, in partnership with actress Naomi Watts, acquiring Stripes Beauty last year.
(Reporting by Abigail Summerville in New York; Editing by David French and Matthew Lewis)
((abigail.summerville@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。